Stage III Prostate Cancer: Clinical Trials

14 trials for Stage III Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated, 2 active not recruiting, 1 withdrawn. 14 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 114Completed 8, Terminated 3, Active not recruiting 2, Withdrawn 1
Phase 23Terminated 2, Completed 1

Follow Stage III Prostate Cancer: new trials by email Literature Review of Stage III Prostate Cancer trials Research Report on Stage III Prostate Cancer

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), Radical Prostatectomy - Stage III Prostate Cancer, Stage IIIA Prostate Cancer
Phase 1WithdrawnSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2018-12-242025-04-29
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma
Phase 1TerminatedUniversity of Southern California22016-08-022021-11-24
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
anti-PSMA monoclonal antibody MDX1201-A488, robot-assisted laparoscopic surgery, diffuse optical imaging - Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer
Phase 1CompletedCity of Hope Medical Center72015-10-052026-10-22
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Enzalutamide, Goserelin acetate, Leuprolide acetate - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
Phase 1Active not recruitingThomas Jefferson University252014-04-022025-11-25
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
green tea extract, quercetin, placebo - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
Phase 1CompletedJonsson Comprehensive Cancer Center322014-01-012021-06-23
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
stereotactic body radiation therapy, quality-of-life assessment, laboratory biomarker analysis - Recurrent Prostate Cancer, Stage I Prostate Cancer
Phase 1Active not recruitingCity of Hope Medical Center262013-11-252026-09-01
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery
Copper Cu 64 TP3805, Positron Emission Tomography, Computed Tomography - Prostate Adenocarcinoma, Stage IIB Prostate Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University252013-08-012025-05-02
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery
lyophilized black raspberry confection, laboratory biomarker analysis, dietary intervention - Stage I Prostate Cancer, Stage IIA Prostate Cancer
Phase 1CompletedOhio State University Comprehensive Cancer Center602012-10-172026-05-20
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma
Phase 1CompletedUniversity of Southern California192010-06-012016-06-13
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients
sunitinib malate, docetaxel, prednisone - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 1 / Phase 2TerminatedJohn P. Fruehauf42009-07-012017-02-01
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
radiation therapy treatment planning/simulation, intensity-modulated radiation therapy, image-guided radiation therapy - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 1CompletedAbramson Cancer Center at Penn Medicine102009-06-012019-07-25
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Calcitriol, Ketoconazole, Laboratory Biomarker Analysis - Prostate Adenocarcinoma, Recurrent Prostate Carcinoma
Phase 1 / Phase 2TerminatedRoswell Park Cancer Institute512006-10-012017-06-14
GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors
GTI-2040, docetaxel, laboratory biomarker analysis - Recurrent Non-small Cell Lung Cancer, Recurrent Prostate Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)482003-10-012013-01-24
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer
Phase 1CompletedNational Cancer Institute (NCI)151999-08-012013-02-28

Narrower conditions

Prostatic Neoplasms (14)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Carcinoma, Renal Cell (3)  ·  Breast Neoplasms (2)  ·  Breast Neoplasms, Male (2)  ·  Carcinoma, Islet Cell (2)  ·  Carcinoma, Medullary (2)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Endometrial Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Adenocarcinoma, Follicular (1)  ·  Adrenocortical Carcinoma (1)  ·  Anus Neoplasms (1)  ·  Appendiceal Neoplasms (1)

Broader conditions

Genital Diseases (14)  ·  Genital Diseases, Male (14)  ·  Genital Neoplasms, Male (14)  ·  Male Urogenital Diseases (14)  ·  Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Prostatic Diseases (14)  ·  Urogenital Diseases (14)  ·  Urogenital Neoplasms (14)  ·  Adenocarcinoma (3)  ·  Bronchial Neoplasms (3)  ·  Carcinoma (3)  ·  Carcinoma, Bronchogenic (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)

Interventions

Docetaxel (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Radiosurgery (2)  ·  CTLA-4 Antigen (1)  ·  Calcitriol (1)  ·  Cystectomy (1)  ·  Diet Therapy (1)  ·  GTI2040 (1)  ·  Goserelin (1)  ·  Hydrocortisone (1)  ·  Interleukin-12 (1)  ·  Interleukin-12 Subunit p35 (1)  ·  Ipilimumab (1)  ·  Ketoconazole (1)  ·  Leuprolide (1)

Sponsors

City of Hope Medical Center (2)  ·  National Cancer Institute (NCI) (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (2)  ·  University of Southern California (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  John P. Fruehauf (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Roswell Park Cancer Institute (1)  ·  Thomas Jefferson University (1)

Countries

United States (12)  ·  Canada (1)

Top investigators

Adam Dicker, MD (1)  ·  Agustin Garcia (1)  ·  Ali Zhumkhawala, MD (1)  ·  David I Quinn, MD (1)  ·  John P Fruehauf, MD, PhD (1)  ·  Madhukar Thakur, MD (1)  ·  Natasha Leighl (1)  ·  Neha Vapiwala (1)  ·  Robert Den, MD (1)  ·  Saby George (1)  ·  Sagus Sampath (1)  ·  Steven Clinton (1)  ·  Susanne Henning, MD (1)  ·  William Carson (1)

Results publications

PMID 27813248, PMID 32112501

NIH funding

N01CM17107 (1), P30CA014089 (1), P30CA016056 (1), R03CA171583 (1), U01CA076576 (1)